We recorded 114 venture capital / private equity (VC/PE) transactions pertaining to the global life sciences sector for January 2021, aggregating to a sum of USD 6.275B. USA recorded 64 transactions for with total investment of USD 4B. China reported investment of USD 1B over 15 VC/PE transactions. India saw…
Read MoreWe recorded 78 VC/PE transactions pertaining to the global life sciences sector for Dec 2020, aggregating to a sum of USD 4.5B. USA recorded 46 transactions for with total investment of USD 2.1B. China reported investment of USD 1.9B over 14 VC/PE transactions. China also reported 3 IPOs aggregating a…
Read MoreWe recorded 81 VC/PE transactions pertaining to the global life sciences sector for Nov 2020, aggregating to a sum of USD 4.7B. USA recorded 46 transactions for with total investment of USD 2.5B. Around 67% of investment, spread over 40 transactions, went into supporting R&D stage companies. Vaccine companies continued…
Read MoreWe recorded 96 VC/PE transactions pertaining to the global life sciences sector for Sep 2020, aggregating to a sum of USD 5.6B. USA recorded 52 transactions for with total investment of USD 2.6B. China reported investment of USD 1.5B over 16 VC/PE transactions. China also reported 2 IPOs aggregating to…
Read MoreAug’20 saw China’s lifescience sector receive more VC/PE investment than the USA for the second time ever in terms of monthly recorded amounts, with the first instance being in Apr’20. For Aug’20, China reported USD 2024m of venture capital investments, as compared to USD 1531m recorded by the USA. China…
Read MoreChina’s biotech sector continues to blossom as far as fund raising goes. For 4 months in a row, the sector is witnessing increasing amounts of fund raise. While private deals (VC/PE) led the increase in April and May, in June and July, it is public market fund raising that drove…
Read MoreWe have earlier commented on the sharply accelerated venture capital activity in the biotech sector in China. From around 2-3 deals a month, aggregating maybe USD100m 2-3 years ago, China is now witnessing close to USD1B of venture capital investments in biotech sector on a monthly basis. Keeping company is…
Read MoreFurious activity is on around the world to come up with a vaccine for the Covid-19 virus. The stakes are high, not just in human life saving imperative, but also likely financial rewards to the company that is first off the block. The active pipeline, as document by the World…
Read MoreAn extremely unfortunate event unfolded on Sunday, when established Bollywood movie star Sushant Singh Rajput committed suicide, purportedly from depression. This brought out in stark relief the scourge of mental illness, of which depression is the most common form. That such a successful person, with no monetary problems, can fall…
Read MoreEarlier this week we wrote how on 2 consecutive months, China’s biotech sector had witnessed more than USD1B of venture capital investment. That chart ignored another source of risk capital – IPOs. China has been producing around 1 biotech IPO a month consistently. These are typically pre-revenue R&D companies, but…
Read More